MeiraGTx Holdings plc (MGTX)

Nasdaq: MGTX · Biological Products, (No Diagnostic Substances) · New York, NY · filing with the SEC since 2018

Grade6.2

◀ Past 7.1● Present 5.9▶ Future 5.7

Overview Business Financials Grade Forecast Sentiment Ownership People Filings Patents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.

Income statement, by fiscal year, newest first
Fiscal year	FY 2025	FY 2024	FY 2023	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Report filed	Mar 30, 2026	Mar 13, 2025	Mar 15, 2024	Mar 14, 2023	Mar 10, 2022	Mar 11, 2021	Mar 11, 2020	Mar 26, 2019	·
Revenue	81,391,000	33,279,000	14,017,000	15,920,000	37,701,000	15,563,000^r	13,291,956	·	·
Research and development	129,619,000	119,484,000	103,785,000	85,725,000	66,694,000^r	33,910,000^r	24,875,659	33,620,223	22,359,712
Sales and marketing	4,843,000	23,791,000	·	·	·	·	·	·	·
General and administrative	52,897,000	54,216,000	47,293,000	46,550,000	43,765,000	44,207,000^r	46,684,297	44,483,938	9,325,017
Total operating expenses	187,359,000	197,491,000	151,078,000	132,275,000	110,459,000^r	78,117,000^r	71,559,956	78,104,161	31,684,729
Operating income	-105,968,000	-164,212,000	-137,061,000	-116,355,000	-72,758,000^r	-62,554,000^r	-58,268,000	-78,104,161	-31,684,729
Interest expense	12,197,000	13,272,000	13,245,000	4,946,000	288,000	139,000^r	48,612	33,429	42,863
Interest and investment income	1,818,000	4,145,000	2,272,000	777,000	212,000	1,275,000^r	370,603	53,408	26,073
Income before income taxes	-114,201,000	-147,791,000	-84,027,000	-129,615,000^r	-79,561,000	-57,992,000^r	-54,746,235	-83,340,265	-31,044,535
Income tax expense	0	0	0	·	0	0	0	-474,391	0
Net income including non-controlling interests	-114,201,000	-147,791,000	-84,027,000	-129,615,000	-79,561,000	-57,992,000^r	-54,746,235	-82,865,874	-31,044,535
Net income	-114,201,000	-147,791,000	-84,027,000	-129,615,000	-79,561,000	-57,992,000^r	-54,746,235	-82,865,874	-31,044,535
Net income to common shareholders	-114,201,000	-147,791,000	-84,027,000	-129,615,000	-79,561,000	-57,992,000^r	-54,746,235	-84,672,386	-31,851,498
Earnings per share, basic	-1.42	-2.12	-1.49	-2.87	-1.80	-1.54	·	·	·
Earnings per share, diluted	-1.42	-2.12	-1.49	-2.87	-1.80	-1.54	·	·	·
Earnings per share, basic and diluted	·	·	·	·	·	-1.54	-1.65	-4.47	-3.72
Weighted average shares, basic	80,430,186	69,822,353	56,486,525	45,177,857	44,139,655	37,724,189	·	·	·
Weighted average shares, diluted	80,430,186	69,822,353	56,486,525	45,177,857	44,139,655	37,724,189	·	·	·
Weighted average shares, basic and diluted	·	·	·	·	·	37,724,189	33,161,860	18,948,520	8,572,315

As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. ^r restated by the company in a later report; ^b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.

What each line is, and the XBRL concept behind it

Revenue what customers paid for what it sold

us-gaap:Revenues
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax

Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense

Sales and marketing the cost of finding and serving customersus-gaap:SellingAndMarketingExpense

General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense

Total operating expenses the running costs togetherus-gaap:OperatingExpenses

Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss

Interest expense what its borrowing costus-gaap:InterestExpense

Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest

Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest

Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit

Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss

Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss

Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic

Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic

Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted

Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted

Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic

Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted

SI Assistanton MGTX · research, not advice